ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026

Dermatologic adverse events associated with amivantamab: A multicentre study.

Vasiliki Nikolaou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.